Concepedia

Paul L. Barclay

PL

Statistics

Publications

13

Citations

462

H-Index

12

Active since

1984

Affiliations

Pfizer (United Kingdom)(Current)

Pfizer (United States)

University of Leeds

Paul L. Barclay is an author at Pfizer (United Kingdom) specializing in medicine, pharmacotherapy, and pharmacology.

Top concepts

Publications per year

1984–2010

13

Publications

13

Lipoatrophy in GH deficient patients treated with a long-acting pegylated GH

Philippe Touraine, Gwyn D'Souza, IONE A. KOURIDES et al. · European Journal of Endocrinology · 2009 · 72 citations · Full text

UK-69, 578, a novel inhibitor of EC 3.4.24.11 which increases endogenous ANF levels and is natriuretic and diuretic

John C. Danilewicz, Paul L. Barclay, I. T. Barnish et al. · Biochemical and Biophysical Research Communications · 1989 · 68 citations

, , +7

The Role of Neutral Endopeptidase in Dogs With Evolving Congestive Heart Failure

Kenneth B. Margulies, Paul L. Barclay, John C. Burnett · Circulation · 1995 · 54 citations

The mechanism of cyclosporine toxicity induced by clarithromycin

S. T. Spicer, Christopher Liddle, Jeremy R. Chapman et al. · British Journal of Clinical Pharmacology · 1997 · 52 citations · Full text

The structure of mammalian rod opsins

J. B. C. Findlay, Paul L. Barclay, M. Brett et al. · Vision Research · 1984 · 38 citations

, , +4

1–5 of 13